Q4 2024 Earnings Call Transcript March 31, 2025 Operator: Welcome to the Precipio Q4 and Year-End 2024 Shareholder Update ...

Precipio Inc (PRPO) reports positive cash flow and revenue growth, while addressing challenges in its product division and enhancing market visibility for 2025.

NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March 31 st, ...

Precipio Inc (PRPO) reports positive cash flow and revenue growth, while addressing challenges in its product division and enhancing market visibility for 2025. Precipio ( NASDAQ:PRPO ) Full Year ...

I n a remarkable display of resilience, Precipio Inc. (NASDAQ:PRPO) stock has soared to a 52-week high, reaching a price ...

NEW HAVEN, Conn., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.(NASDAQ: PRPO), announces that it has achieved two important financial goals in the last ...

U.S. stocks traded higher toward the end of trading, with Dow Jones gaining more than 150 points on Thursday. The Dow traded up 0.53% to 33,844.18 while the NASDAQ rose 0.90% to 13,223.26.

Welcome to the Precipio Q4 and Year-End 2024 Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note that the conference is being ...

NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March ...

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell ...

NEW HAVEN, Conn., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that it has achieved two important financial goals in the last quarter ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...